HUMAN REPRODUCTION UPDATE, published by Oxford University Press, stands as a leading journal in the fields of Obstetrics and Gynecology and Reproductive Medicine. With an impressive Q1 ranking in both categories according to the 2023 category quartiles and a significant Scopus rank, it is recognized as one of the top journals globally in these disciplines, catering to the most relevant and cutting-edge research. The journal has been a crucial platform for disseminating vital findings and reviews from 1995 to 2024, contributing to advancements in human reproductive health. With its focus on publishing high-quality, peer-reviewed articles, it serves as an essential resource for researchers, healthcare professionals, and students seeking the latest insights and developments in reproductive science. As the journal aims to foster informed discussions and encourage further research, it remains committed to shaping the future of reproductive health and medicine.

Aktualni Gynekologie a Porodnictvi is a prominent scholarly journal dedicated to the fields of gynecology and obstetrics, published by APROFEMA SRO in the heart of Prague, Czech Republic. With a focus on the latest advancements and practices in women's health, this journal serves as an essential resource for researchers, healthcare professionals, and students alike. Although detailed impact metrics such as HIndex and Scopus rankings are currently unspecified, the journal's commitment to peer-reviewed quality ensures that it disseminates significant contributions to the discipline. The absence of open access may enhance the depth of discourse by fostering community engagement through subscription-based distribution. By bridging clinical practice with innovative research, Aktualni Gynekologie a Porodnictvi remains a vital platform for those invested in the evolving landscape of gynecological and obstetric care.

The Journal of Gynecology Obstetrics and Human Reproduction, published by Elsevier Masson, is an esteemed platform dedicated to advancing knowledge in the fields of gynecology, obstetrics, and reproductive medicine. Established in 2016, this journal has quickly gained prominence, currently holding a Q2 ranking in both Obstetrics and Gynecology, as well as Reproductive Medicine, as of 2023. With its base in France, the journal aims to provide crucial insights and the latest research findings, catering to a diverse audience of researchers, professionals, and students. The journal operates under the open access model, ensuring that high-quality articles are freely accessible, fostering collaboration and knowledge exchange among practitioners and scholars. With a broad scope covering various facets of women's health, the Journal of Gynecology Obstetrics and Human Reproduction is committed to contributing to the advancement of research and practice in these vital fields.

Revista Brasileira de Ginecologia e Obstetricia is a renowned academic journal based in Brazil, published by GEORG THIEME VERLAG KG, dedicated to advancing research in the fields of gynecology and obstetrics. With an Open Access policy since 1998, this journal ensures that critical findings and insights remain accessible to a global audience, fostering collaboration and knowledge sharing among healthcare professionals and researchers. The journal has maintained a respectable position within its field, currently ranked Q3 in Obstetrics and Gynecology according to the 2023 category quartiles, and holds a Scopus rank of 122 out of 209, placing it in the 41st percentile. Covering a wide array of topics pertinent to women's health, the Revista Brasileira de Ginecologia e Obstetricia serves as a vital platform for disseminating new research, clinical practices, and reviews, contributing to the enhanced understanding and treatment of gynecological and obstetrical conditions. The journal not only supports academic rigor but also empowers professionals and students in their pursuit of excellence in women's health.

GYNECOLOGIC AND OBSTETRIC INVESTIGATION, published by KARGER, is an influential journal dedicated to advancing the fields of obstetrics and gynecology. With an ISSN of 0378-7346 and E-ISSN 1423-002X, this esteemed publication has been disseminating pivotal research since 1895 and continues to serve as an authoritative source through its convergence until 2024. Renowned for its rigorous adherence to academic standards, it stands in the Q2 category for both Obstetrics and Gynecology and Reproductive Medicine as of 2023, reflecting its quality and impact within the scientific community. With Scopus rankings highlighting its commendable positions—Rank #66 in Obstetrics and Gynecology and Rank #31 in Reproductive Medicine—it is an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of women’s health issues and innovative care practices. Despite not being an open-access journal, its contributions significantly influence current and future directions in clinical and translational research.

BJOG - An International Journal of Obstetrics and Gynaecology is a leading peer-reviewed journal in the field of obstetrics and gynecology, published by Wiley in the United Kingdom. With a rich history dating back to 1902, this esteemed journal is recognized for its significant contribution to advancing clinical practice and research, consistently ranking in the top tier (Q1) of its category, according to the 2023 Scopus rankings. Representing the best of 209 journals in the discipline, BJOG is dedicated to publishing high-quality research and innovative insights that address critical issues in women's health. While not an open-access journal, it provides valuable access options for institutions and individuals to stay informed about the latest developments and evidence-based practices. The journal's commitment to disseminating cutting-edge research makes it an essential resource for clinicians, researchers, and academics aiming to improve health outcomes in obstetrics and gynecology.

GYNECOLOGICAL ENDOCRINOLOGY is a prestigious open-access journal published by Taylor & Francis Ltd, focusing on the dynamic fields of endocrinology, obstetrics, and gynecology. With its ISSN of 0951-3590 and E-ISSN of 1473-0766, this journal provides a vital platform for the dissemination of high-quality research and advancements in gynecological endocrinology since its inception in 1987. Notably, it attained an Open Access status in 2023, enhancing its reach and accessibility to researchers and practitioners worldwide. The journal is renowned for its rigorous peer-review process and holds significant standing with a Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Endocrinology, Diabetes, and Metabolism, as of 2023. It is indexed with commendable Scopus ranks in various medical domains, offering a reliable resource for current methodologies and future directions in gynecological health. With the growing emphasis on women's health and endocrinological research, GYNECOLOGICAL ENDOCRINOLOGY serves as an essential repository for innovative studies, clinical insights, and emerging therapeutic strategies, making it an invaluable resource for researchers, clinicians, and students alike.

Welcome to the European Journal of Obstetrics & Gynecology and Reproductive Biology, a premier publication dedicated to advancing the fields of obstetrics, gynecology, and reproductive medicine. Published by Elsevier, this journal has been a vital resource since its inception in 1971, continuing to provide high-quality, peer-reviewed research through 2024 and beyond. With an impressive impact factor and recognized in the Q2 quartile for both obstetrics and gynecology, as well as reproductive medicine, it ranks among the top journals in its field, being positioned at #59 out of 209 in Obstetrics and Gynecology and #29 out of 90 in Reproductive Medicine. Though not currently an Open Access journal, it remains committed to disseminating valuable findings to enhance clinical practice and facilitate further research. Researchers, professionals, and students can expect insightful articles, comprehensive reviews, and pioneering studies that significantly impact women's health and reproductive biology.

Clinical and Experimental Obstetrics & Gynecology is a prominent journal published by IMR PRESS, dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Since its establishment in 1974, this journal has been a crucial platform for the dissemination of research findings, innovative practices, and reviews that contribute to the advancement of women's health. With an Open Access model adopted in 2019, it ensures that high-quality research is accessible to all stakeholders in the field, thus promoting greater collaboration and knowledge sharing. Based in Hong Kong, the journal is indexed under various categories with a 2023 Quartile ranking of Q3 in Obstetrics and Gynecology and Q4 in Reproductive Medicine, affirming its role in shaping the academic conversation within these disciplines. Despite its current Scopus rankings placing it in the lower percentiles, the journal continues to grow in influence, making it an essential resource for researchers, healthcare professionals, and students aiming to stay at the forefront of clinical and experimental innovations in obstetrics and gynecology.

Obstetrics & Gynecology Science is a premier journal in the field of obstetrics and gynecology, published by the Korean Society of Obstetrics and Gynecology (KSOG). With an ISSN of 2287-8572 and an E-ISSN of 2287-8580, this journal has established a solid reputation for disseminating high-quality research since its transition to an Open Access model in 2010. Situated in South Korea, the journal contributes significantly to the global academic discourse, evidenced by its categorization in Q2 for Obstetrics and Gynecology as of 2023, and its notable Scopus ranking of #75 out of 209 in the Medicine category, reflecting a commendable 64th percentile ranking. The scope of the journal covers diverse research areas relevant to both established practitioners and emerging scholars, aiming to foster innovation and knowledge transfer in women's health. As the journal converges its focus from 2017 to 2024, it continues to be an essential resource for researchers, healthcare professionals, and students dedicated to advancing their understanding and practice in this vital field of medicine.